top of page
About Us
CEO Message
History
Contact Us
R&D
Core Technology
Publications
Pipeline
IMB001
IMB002
IR/PR
Notice
Press Release
Career
Recruitment Information
Talents
Employee Benefits
< Back
이뮤노바이옴 “마이크로바이옴 염증질환 치료제, 4분기 1상 신청”
한국경제
Previous
Next
bottom of page